The litigation targets a series of stock price collapses triggered by consecutive earnings disappointments. In November 2025, Doximity shares plummeted 13.25% after the company signaled an impending slowdown in ad spending. The decline deepened on February 6, 2026, when the firm reported decelerating sales and shrinking net income, causing a 16.78% single-day drop to $27.73 per share.
Doximity Faces Class Action Lawsuit Over Securities Fraud Allegations
Investors who suffered losses holding Doximity, Inc. stock have until November 16, 2026, to seek appointment as lead plaintiff in a class action lawsuit. Pomerantz LLP filed the claim, alleging the company and its leadership engaged in deceptive business practices that obscured the severity of its slowing financial growth.
The final blow arrived in May 2026, when Doximity failed to meet its already lowered revenue guidance and issued a pessimistic outlook for the 2027 fiscal year. The stock fell another 23% to $18.01, prompting multiple analyst downgrades. Investors seeking to participate in the legal action can contact Danielle Peyton at Pomerantz LLP to formalize their claims before the November deadline.
Comments (0)
No comments yet. Be the first!